Coulie Bernard 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jan 24, 2024
Insider Transaction Report
Form 4
Coulie Bernard
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-01-23+128,150→ 444,532 total - Award
Stock Option (Right to Buy)
2024-01-23+256,300→ 256,300 totalExercise: $17.44Exp: 2034-01-23→ Common Stock (256,300 underlying)
Holdings
- 409,317(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F2]Shares held by The Coulie/Leyman Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.